Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Total Current Liabilities: 2016-2025

Historic Total Current Liabilities for Mesoblast (MESO) over the last 10 years, with Jun 2025 value amounting to $102.6 million.

  • Mesoblast's Total Current Liabilities rose 40.12% to $102.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $102.6 million, marking a year-over-year increase of 40.12%. This contributed to the annual value of $102.6 million for FY2025, which is 40.12% up from last year.
  • Mesoblast's Total Current Liabilities amounted to $102.6 million in FY2025, which was up 40.12% from $73.2 million recorded in FY2024.
  • In the past 5 years, Mesoblast's Total Current Liabilities ranged from a high of $102.6 million in FY2025 and a low of $42.0 million during FY2023.
  • Moreover, its 3-year median value for Total Current Liabilities was $73.2 million (2024), whereas its average is $72.6 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first slumped by 45.51% in 2022, then skyrocketed by 74.46% in 2024.
  • Yearly analysis of 5 years shows Mesoblast's Total Current Liabilities stood at $94.3 million in 2021, then tumbled by 45.51% to $51.4 million in 2022, then declined by 18.28% to $42.0 million in 2023, then skyrocketed by 74.46% to $73.2 million in 2024, then spiked by 40.12% to $102.6 million in 2025.